Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05456880 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Beam Therapeutics Inc. |
| Last Updated on CT.gov | December 16, 2025 (Dec 16, 2025) |
As of March 2, 2026: Clinical trial NCT05456880 is currently active_not_recruiting participants. This clinical trial study for sickle cell disease is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Beam Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05456880 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05456880 was last updated Dec 16, 2025 (December 16, 2025). HelloStudys verifies this status automatically.